Cargando…

The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research

Background: Biobanks play a critical role in cancer research by providing high quality biological samples for research. However, the availability of tumor samples in single research institutions is often limited, especially for rare cancers. In order to facilitate the search for samples scattered am...

Descripción completa

Detalles Bibliográficos
Autores principales: Vande Loock, Kim, Van der Stock, Eva, Debucquoy, Annelies, Emmerechts, Katia, Van Damme, Nancy, Marbaix, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554332/
https://www.ncbi.nlm.nih.gov/pubmed/31214591
http://dx.doi.org/10.3389/fmed.2019.00120
_version_ 1783424951801348096
author Vande Loock, Kim
Van der Stock, Eva
Debucquoy, Annelies
Emmerechts, Katia
Van Damme, Nancy
Marbaix, Etienne
author_facet Vande Loock, Kim
Van der Stock, Eva
Debucquoy, Annelies
Emmerechts, Katia
Van Damme, Nancy
Marbaix, Etienne
author_sort Vande Loock, Kim
collection PubMed
description Background: Biobanks play a critical role in cancer research by providing high quality biological samples for research. However, the availability of tumor samples in single research institutions is often limited, especially for rare cancers. In order to facilitate the search for samples scattered among different Belgian institutions, a nationwide virtual tumorbank project was launched and is operational since February 2012. The Belgian Virtual Tumorbank (BVT) network encompasses the tumor biobanks from eleven Belgian university hospitals that collect and store residual human tumor samples locally and is coordinated by the Belgian Cancer Registry. Materials and Methods: A web application was developed and consists of two modules. The registration module (BVTr) centralizes the tumor sample data from the local partner biobanks. The catalog module (BVTc) allows researchers to trace the tumor samples in the 11 tumor biobanks. The BVTc contains patient, medical and technical data, but excludes identifying information to ensure privacy of individuals. Automatic and manual controls guarantee high quality data on the samples requested by scientists for research purposes in oncology. A major advantage of the BVT network is that the available data can be linked to the data of the Belgian Cancer Registry for quality control purposes. Results: Currently, more than 92,000 registrations are available in the catalog. Twenty-seven percent of the residual primary tumor samples originate from breast tissue, but also less frequent localisations such as head and neck (4%), male genital organs (1.7%), and urinary tract (1%) are available. In addition to the residual tumor tissue samples, also other available material can be stored and registered by the local biobanks. The most common type is corresponding normal tissue (19%).Other frequently available materials are plasma, blood, serum, DNA, and buffy coat. Even PBMCs, RNA, cytology, and urine are available in some cases. Discussion and Conclusion: The BVT catalog is a valuable source of information for oncology research and the ultimate goal is to promote multidisciplinary cancer research (i.e., pathogenesis, disease prediction, prevention, diagnosis, treatment, and prognosis) for the benefit of all cancer patients.
format Online
Article
Text
id pubmed-6554332
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65543322019-06-18 The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research Vande Loock, Kim Van der Stock, Eva Debucquoy, Annelies Emmerechts, Katia Van Damme, Nancy Marbaix, Etienne Front Med (Lausanne) Medicine Background: Biobanks play a critical role in cancer research by providing high quality biological samples for research. However, the availability of tumor samples in single research institutions is often limited, especially for rare cancers. In order to facilitate the search for samples scattered among different Belgian institutions, a nationwide virtual tumorbank project was launched and is operational since February 2012. The Belgian Virtual Tumorbank (BVT) network encompasses the tumor biobanks from eleven Belgian university hospitals that collect and store residual human tumor samples locally and is coordinated by the Belgian Cancer Registry. Materials and Methods: A web application was developed and consists of two modules. The registration module (BVTr) centralizes the tumor sample data from the local partner biobanks. The catalog module (BVTc) allows researchers to trace the tumor samples in the 11 tumor biobanks. The BVTc contains patient, medical and technical data, but excludes identifying information to ensure privacy of individuals. Automatic and manual controls guarantee high quality data on the samples requested by scientists for research purposes in oncology. A major advantage of the BVT network is that the available data can be linked to the data of the Belgian Cancer Registry for quality control purposes. Results: Currently, more than 92,000 registrations are available in the catalog. Twenty-seven percent of the residual primary tumor samples originate from breast tissue, but also less frequent localisations such as head and neck (4%), male genital organs (1.7%), and urinary tract (1%) are available. In addition to the residual tumor tissue samples, also other available material can be stored and registered by the local biobanks. The most common type is corresponding normal tissue (19%).Other frequently available materials are plasma, blood, serum, DNA, and buffy coat. Even PBMCs, RNA, cytology, and urine are available in some cases. Discussion and Conclusion: The BVT catalog is a valuable source of information for oncology research and the ultimate goal is to promote multidisciplinary cancer research (i.e., pathogenesis, disease prediction, prevention, diagnosis, treatment, and prognosis) for the benefit of all cancer patients. Frontiers Media S.A. 2019-05-31 /pmc/articles/PMC6554332/ /pubmed/31214591 http://dx.doi.org/10.3389/fmed.2019.00120 Text en Copyright © 2019 Vande Loock, Van der Stock, Debucquoy, Emmerechts, Van Damme and Marbaix. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Vande Loock, Kim
Van der Stock, Eva
Debucquoy, Annelies
Emmerechts, Katia
Van Damme, Nancy
Marbaix, Etienne
The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research
title The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research
title_full The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research
title_fullStr The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research
title_full_unstemmed The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research
title_short The Belgian Virtual Tumorbank: A Tool for Translational Cancer Research
title_sort belgian virtual tumorbank: a tool for translational cancer research
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554332/
https://www.ncbi.nlm.nih.gov/pubmed/31214591
http://dx.doi.org/10.3389/fmed.2019.00120
work_keys_str_mv AT vandeloockkim thebelgianvirtualtumorbankatoolfortranslationalcancerresearch
AT vanderstockeva thebelgianvirtualtumorbankatoolfortranslationalcancerresearch
AT debucquoyannelies thebelgianvirtualtumorbankatoolfortranslationalcancerresearch
AT emmerechtskatia thebelgianvirtualtumorbankatoolfortranslationalcancerresearch
AT vandammenancy thebelgianvirtualtumorbankatoolfortranslationalcancerresearch
AT marbaixetienne thebelgianvirtualtumorbankatoolfortranslationalcancerresearch
AT vandeloockkim belgianvirtualtumorbankatoolfortranslationalcancerresearch
AT vanderstockeva belgianvirtualtumorbankatoolfortranslationalcancerresearch
AT debucquoyannelies belgianvirtualtumorbankatoolfortranslationalcancerresearch
AT emmerechtskatia belgianvirtualtumorbankatoolfortranslationalcancerresearch
AT vandammenancy belgianvirtualtumorbankatoolfortranslationalcancerresearch
AT marbaixetienne belgianvirtualtumorbankatoolfortranslationalcancerresearch